CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The Antiviral System of Bacteria and Archaea: CRISPR
Conservative Site-specific Recombination and Phase Variation
Experimental RNAi
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 27, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
1State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
This review examines how CRISPR-Cas systems, originally evolved for bacterial defense, are now used as versatile tools to detect, edit, and study RNA molecules in various organisms. It highlights the diverse mechanisms these systems use to target RNA and discusses their current applications in cellular research.
Area of Science:
Background:
Scientists currently lack a comprehensive synthesis of how diverse prokaryotic defense systems function as programmable tools for RNA regulation. Prior research has shown that adaptive immunity relies on RNA-guided endonucleases to neutralize foreign genetic material. That uncertainty drove the need to categorize the specific mechanisms of various Cas effectors. It was already known that type II, V, VI, and III complexes possess distinct structural properties. This gap motivated an investigation into how these proteins recognize and process ribonucleic acid targets. No prior work had resolved the full spectrum of current functional applications across different cellular environments. Researchers have long utilized these systems for basic genetic studies, yet the breadth of recent advancements remains fragmented. This review provides a unified framework to understand the evolution of these molecular technologies.
Purpose Of The Study:
The aim of this review is to summarize the current understanding of the mechanistic and functional characteristics of various Cas effectors. This work addresses the need for a unified overview of the rapidly evolving field of RNA-guided technologies. The authors seek to categorize the diverse platforms that have been established for selective RNA targeting. This investigation explores how these systems are applied to knockdown, editing, and imaging of cellular transcripts. The researchers intend to clarify the differences in target recognition and cleavage mechanisms among various types of complexes. This study provides a necessary synthesis of the current toolbox for mapping protein-RNA interactions. The motivation stems from the increasing importance of these tools in both basic research and potential therapeutic applications. This review serves as a guide for scientists looking to implement these programmable systems in their own experimental designs.
Main Methods:
Review Approach framing involves a systematic synthesis of existing literature regarding prokaryotic adaptive immunity. The authors analyzed peer-reviewed studies detailing the functional characteristics of various Cas effectors. This approach prioritized data concerning ribonucleoprotein assembly and target recognition pathways. The investigators evaluated experimental outcomes from both prokaryotic and eukaryotic model systems. They utilized a comparative framework to assess the efficacy of different RNA-targeting platforms. This methodology included a comprehensive survey of current techniques for imaging and mapping molecular interactions. The team synthesized findings from diverse studies to categorize the current state of the field. This rigorous assessment provides a clear overview of the technological landscape for genetic engineering.
Main Results:
Key Findings From the Literature indicate that type II, V, VI, and III complexes are the most effective platforms for selective RNA targeting. The authors report that these effectors demonstrate remarkable diversity in their ribonucleoprotein composition and cleavage mechanisms. Research shows that these systems can be successfully adapted for knockdown, editing, and imaging of transcripts. The literature confirms that these tools function reliably within both prokaryotic and eukaryotic cellular environments. Studies highlight that self-discrimination mechanisms are essential for preventing off-target effects during RNA processing. The authors note that current mapping techniques allow for the precise identification of protein-RNA interactions. Data suggest that the modularity of these effectors enables a wide range of functional applications. The review confirms that these programmable systems have significantly expanded the capabilities of modern molecular biology.
Conclusions:
The authors propose that the diversity of Cas effectors offers a robust foundation for future biotechnological innovation. They suggest that ongoing characterization of ribonucleoprotein complexes will expand the precision of current genetic toolboxes. Synthesis and Implications reveal that RNA-guided systems provide unique advantages over traditional protein-based regulatory methods. The researchers indicate that current platforms for imaging and mapping interactions are already transforming cellular biology. They highlight that the modular nature of these effectors allows for rapid adaptation to new experimental requirements. The review concludes that refining self-discrimination mechanisms will improve the safety of therapeutic applications. The authors maintain that continued exploration of these systems will yield novel insights into post-transcriptional regulation. This work underscores the potential for highly specific molecular interventions in both prokaryotic and eukaryotic models.
The researchers propose that Cas effectors utilize RNA-guided endonucleases to recognize and cleave specific sequences. Unlike traditional methods, these systems leverage diverse ribonucleoprotein compositions to achieve high selectivity in target identification, distinguishing between foreign and endogenous nucleic acids through unique self-discrimination mechanisms.
The authors categorize the toolbox into knockdown, editing, imaging, modification, and mapping of protein-RNA interactions. These applications utilize different Cas effectors, such as type VI Cas13 or type III complexes, to perform distinct regulatory tasks depending on the experimental goal.
The authors state that understanding the structural diversity of ribonucleoprotein complexes is necessary to optimize target recognition. Without these specific mechanistic details, researchers cannot effectively distinguish between various Cas effectors or predict their performance in complex cellular environments.
The review indicates that these effectors serve as the functional core of the platform. By leveraging their natural ability to bind and process nucleic acids, scientists can program these proteins to interact with specific transcripts for detection or modification purposes.
The researchers discuss the phenomenon of target cleavage as a key metric for efficacy. They compare the specificity of type II, V, VI, and III systems, noting that each exhibits different kinetic properties when interacting with RNA molecules in eukaryotic cells.
The authors propose that future developments will focus on enhancing the precision of RNA editing and mapping. They suggest that overcoming current limitations in delivery and specificity will allow these tools to be used more effectively in clinical and diagnostic settings.